CN

News

Size: LMS

Strength Certification | Shandong Xinbo Clinical Laboratory Achieves' Satisfactory 'Results in Four Core Projects

2025/12/03

Shandong Xinbo, with its excellent testing level and technical team, achieved "satisfactory" results in four core projects: urine biochemical index detection, blood coagulation index detection, serum biochemical index detection, and hematological index detection in the 2025 clinical laboratory held by the China Academy of Food and Drug Control.

This is not only an authoritative recognition of Shandong Xinbo's clinical laboratory technology level by the industry, but also means that we can provide more reliable laboratory data support for scientific research institutions, pharmaceutical companies, universities and other partners, safeguarding the accuracy of diagnosis, treatment and research from the source!


Jinan Laboratory

Linyi Laboratory

Four core tests are fully covered, accurately adapting to the needs of multiple clinical scenarios
The four tests that have been certified this time are all key projects with high clinical application frequency and diagnostic reference value, which can fully meet the testing needs of different scenarios:
Detection of urinary biochemical indicators: through the detection of urinary protein, urine sugar, urinary ketone body and other indicators, it assists in the early screening and condition monitoring of chronic kidney disease, diabetes, urinary system infection and other diseases, and is the "basic just needed project" of basic medical and physical examination centers;

 Blood coagulation index detection: Focusing on core indicators such as prothrombin time (PT) and activated partial thromboplastin time (APTT), providing key basis for preoperative coagulation function evaluation, monitoring of anticoagulant drug efficacy, and diagnosis of bleeding diseases, directly related to diagnosis and treatment safety;

● Serum biochemical index detection: covering liver function (ALT, AST), kidney function (creatinine, urea nitrogen), blood lipids (total cholesterol, triglycerides) and other indicators, it is a "core reference item" for evaluating organ function and judging metabolic diseases, widely used in health checkups and chronic disease management;

● Hematological index testing: Through blood routine (white blood cell, red blood cell, platelet count), blood cell morphology analysis, etc., it assists in the preliminary diagnosis of anemia, infection, and hematological diseases, and is the basic item of "first diagnosis must check" in clinical diagnosis and treatment.

Three core advantages to strengthen the credibility of testing results
It is not accidental that all four projects achieved satisfactory results simultaneously - behind it is the technical accumulation of Shandong Xinbo's long-term deep cultivation in the field of clinical testing:
✅ Senior inspection team control: The inspection team has an average of more than 8 years of clinical inspection experience, familiar with the operational difficulties and quality control points of various testing projects. In response to the characteristics of "strong sample timeliness" and "high counting accuracy requirements" of hematological indicators in coagulation testing, a special SOP has been developed to avoid operational errors throughout the process;
✅ High end equipment precision empowerment: equipped with industry-leading equipment such as fully automatic biochemical analyzers, coagulation analyzers, urine analyzers, and five class blood cell analyzers, supporting synchronous detection of multiple items, not only shortening the reporting cycle, but also ensuring data repeatability and accuracy;
✅ Full process quality control system: Establish a triple quality control mechanism of "sample traceability+dual person review+positive control verification" - from sample reception, processing to detection, scan code traceability throughout the entire process; The test results will be blindly reviewed by senior technicians; Before starting up each day, calibrate the instrument with standard samples to ensure that each report is "verifiable".



About Shandong Xinbo
Shandong Xinbo was established in April 2010, with Jinan Laboratory and Linyi Laboratory. It is a national high-tech enterprise, Shandong Enterprise Technology Center, Shandong Gazelle Enterprise, and a research service-oriented enterprise that integrates pharmacological research, toxicology research, drug analysis and testing services, animal pathology testing, and medical device evaluation services. We have completed preclinical safety evaluations for over 400 innovative drugs, including chemical drugs, traditional Chinese medicine and natural medicines, biological products, preventive and therapeutic vaccines, monoclonal antibodies, cell therapy products, medical devices, and other varieties.




Did you find the information you needed?

Great, thank you for your feedback.
Thank you for your feedback.